Literature DB >> 18498004

The actin cytoskeleton in cancer cell motility.

Michael F Olson1, Erik Sahai.   

Abstract

Cancer cell metastasis is a multi-stage process involving invasion into surrounding tissue, intravasation, transit in the blood or lymph, extravasation, and growth at a new site. Many of these steps require cell motility, which is driven by cycles of actin polymerization, cell adhesion and acto-myosin contraction. These processes have been studied in cancer cells in vitro for many years, often with seemingly contradictory results. The challenge now is to understand how the multitude of in vitro observations relates to the movement of cancer cells in living tumour tissue. In this review we will concentrate on actin protrusion and acto-myosin contraction. We will begin by presenting some general principles summarizing the widely-accepted mechanisms for the co-ordinated regulation of actin polymerization and contraction. We will then discuss more recent studies that investigate how experimental manipulation of actin dynamics affects cancer cell invasion in complex environments and in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498004     DOI: 10.1007/s10585-008-9174-2

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  131 in total

Review 1.  Formin-induced nucleation of actin filaments.

Authors:  Sally H Zigmond
Journal:  Curr Opin Cell Biol       Date:  2004-02       Impact factor: 8.382

2.  Tumor cell migration in three dimensions.

Authors:  Steven Hooper; John F Marshall; Erik Sahai
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Authors:  Masumi Eto; Toshio Kitazawa; Fumiko Matsuzawa; Sei-Ichi Aikawa; Jason A Kirkbride; Noriyoshi Isozumi; Yumi Nishimura; David L Brautigan; Shin-Ya Ohki
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

4.  Life and times of a cellular bleb.

Authors:  Guillaume T Charras; Margaret Coughlin; Timothy J Mitchison; L Mahadevan
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

5.  Disruption of the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 as an effector for Cdc42.

Authors:  Jun Peng; Bradley J Wallar; Akiko Flanders; Pamela J Swiatek; Arthur S Alberts
Journal:  Curr Biol       Date:  2003-04-01       Impact factor: 10.834

6.  Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.

Authors:  Hongchuan Jin; Tobias Sperka; Peter Herrlich; Helen Morrison
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

7.  Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton.

Authors:  Eniko Kiss; Andrea Murányi; Csilla Csortos; Pál Gergely; Masaaki Ito; David J Hartshorne; Ferenc Erdodi
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

8.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

9.  Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin.

Authors:  K Takenaga; Y Nakamura; S Sakiyama; Y Hasegawa; K Sato; H Endo
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

10.  The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors.

Authors:  Weigang Wang; Ghassan Mouneimne; Mazen Sidani; Jeffrey Wyckoff; Xiaoming Chen; Anastasia Makris; Sumanta Goswami; Anne R Bresnick; John S Condeelis
Journal:  J Cell Biol       Date:  2006-05-01       Impact factor: 10.539

View more
  217 in total

1.  Biophysical control of invasive tumor cell behavior by extracellular matrix microarchitecture.

Authors:  Shawn P Carey; Casey M Kraning-Rush; Rebecca M Williams; Cynthia A Reinhart-King
Journal:  Biomaterials       Date:  2012-03-08       Impact factor: 12.479

Review 2.  The ROCK signaling and breast cancer metastasis.

Authors:  Sijin Liu
Journal:  Mol Biol Rep       Date:  2010-07-03       Impact factor: 2.316

3.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

4.  Myosin light chain mono- and di-phosphorylation differentially regulate adhesion and polarity in migrating cells.

Authors:  Miguel Vicente-Manzanares; Alan Rick Horwitz
Journal:  Biochem Biophys Res Commun       Date:  2010-10-28       Impact factor: 3.575

5.  MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition.

Authors:  Jie Lin; Yihui He; Lingfeng Chen; Xiaoyan Chen; Shengbing Zang; Wansong Lin
Journal:  Clin Exp Med       Date:  2018-05-31       Impact factor: 3.984

6.  p38 mitogen-activated protein kinase interacts with vinculin at focal adhesions during fatty acid-stimulated cell adhesion.

Authors:  Margaret D George; Robert N Wine; Brad Lackford; Grace E Kissling; Steven K Akiyama; Kenneth Olden; John D Roberts
Journal:  Biochem Cell Biol       Date:  2013-06-24       Impact factor: 3.626

7.  Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.

Authors:  Mari Gasparyan; Miao-Chia Lo; Hui Jiang; Chang-Ching Lin; Duxin Sun
Journal:  J Biol Chem       Date:  2020-05-28       Impact factor: 5.157

8.  RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

Authors:  Ronil A Patel; Kara D Forinash; Roberta Pireddu; Ying Sun; Nan Sun; Mathew P Martin; Ernst Schönbrunn; Nicholas J Lawrence; Saïd M Sebti
Journal:  Cancer Res       Date:  2012-07-30       Impact factor: 12.701

9.  Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis.

Authors:  Pierre Morin; Cristina Flors; Michael F Olson
Journal:  Eur J Cell Biol       Date:  2009-06-09       Impact factor: 4.492

10.  Cdc42 antagonizes Rho1 activity at adherens junctions to limit epithelial cell apical tension.

Authors:  Stephen J Warner; Gregory D Longmore
Journal:  J Cell Biol       Date:  2009-10-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.